[EN] METHOD FOR DETERMINING THE HER2 STATUS OF A MALIGNANCY<br/>[FR] PROCÉDÉ DE DÉTERMINATION DU STATUT HER2 D'UNE TUMEUR MALIGNE
申请人:AFFIBODY AB
公开号:WO2014013016A1
公开(公告)日:2014-01-23
A method for determining the HER2 status of a malignancy is provided. The method comprises administering, to a mammalian subject having a malignancy suspected of being HER2 positive, a tracer molecule comprising a HER2 binding polypeptide; measuring the amount of said tracer molecule present in said malignancy using medical imaging equipment at two time points t1 and t2 to yield a first and second value; comparing said first and second values, and if said second value is greater than said first value, concluding that the malignancy of said subject is HER2 positive.